The Valley Desk

NCT06112314 · Interventional trial

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Overall registry status Recruiting

Phase 3

Conditions Advanced Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov